vs
亚什兰（ASH）与Healthpeak Properties（DOC）财务数据对比。点击上方公司名可切换其他公司
Healthpeak Properties的季度营收约是亚什兰的1.9倍（$719.4M vs $386.0M），Healthpeak Properties净利率更高（73.2% vs -3.1%，领先76.3%），Healthpeak Properties同比增速更快（3.1% vs -4.7%），Healthpeak Properties自由现金流更多（$357.0M vs $111.0M），过去两年Healthpeak Properties的营收复合增速更高（8.9% vs -18.1%）
亚什兰是一家总部位于美国特拉华州威尔明顿的化工企业，1924年始创于肯塔基州亚什兰市，最初以炼油业务起家，1994年迁至现总部。公司拥有多个业务板块，覆盖化工中间体与溶剂、复合材料、工业特种化学品、个人及家居护理、制药、食品饮料以及农业相关领域，2017年之前曾是胜牌润滑油的主要生产商。
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
ASH vs DOC — 直观对比
营收规模更大
DOC
是对方的1.9倍
$386.0M
营收增速更快
DOC
高出7.8%
-4.7%
净利率更高
DOC
高出76.3%
-3.1%
自由现金流更多
DOC
多$246.0M
$111.0M
两年增速更快
DOC
近两年复合增速
-18.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $386.0M | $719.4M |
| 净利润 | $-12.0M | $114.0M |
| 毛利率 | 27.2% | — |
| 营业利润率 | -1.6% | 17.4% |
| 净利率 | -3.1% | 73.2% |
| 营收同比 | -4.7% | 3.1% |
| 净利润同比 | 92.7% | 2406.4% |
| 每股收益（稀释后） | $-0.26 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASHDOC
| Q4 25 | $386.0M | $719.4M | ||
| Q3 25 | $477.0M | $705.9M | ||
| Q2 25 | $463.0M | $694.3M | ||
| Q1 25 | $479.0M | $702.9M | ||
| Q4 24 | $405.0M | $698.0M | ||
| Q3 24 | $521.0M | $700.4M | ||
| Q2 24 | $544.0M | $695.5M | ||
| Q1 24 | $575.0M | $606.6M |
净利润ASHDOC
| Q4 25 | $-12.0M | $114.0M | ||
| Q3 25 | $31.0M | $-117.1M | ||
| Q2 25 | $-742.0M | $31.7M | ||
| Q1 25 | $31.0M | $42.8M | ||
| Q4 24 | $-165.0M | $4.5M | ||
| Q3 24 | $17.0M | $85.9M | ||
| Q2 24 | $6.0M | $146.0M | ||
| Q1 24 | $120.0M | $6.7M |
毛利率ASHDOC
| Q4 25 | 27.2% | — | ||
| Q3 25 | 33.3% | 58.6% | ||
| Q2 25 | 28.5% | 60.2% | ||
| Q1 25 | 30.7% | 61.1% | ||
| Q4 24 | 27.4% | 60.3% | ||
| Q3 24 | 33.2% | 60.0% | ||
| Q2 24 | 34.2% | 60.6% | ||
| Q1 24 | 28.0% | 59.8% |
营业利润率ASHDOC
| Q4 25 | -1.6% | 17.4% | ||
| Q3 25 | 12.8% | 9.2% | ||
| Q2 25 | -152.9% | 5.7% | ||
| Q1 25 | 10.6% | 7.7% | ||
| Q4 24 | -44.2% | -2.2% | ||
| Q3 24 | 6.1% | 14.1% | ||
| Q2 24 | -11.2% | 22.3% | ||
| Q1 24 | 3.7% | 3.7% |
净利率ASHDOC
| Q4 25 | -3.1% | 73.2% | ||
| Q3 25 | 6.5% | -16.6% | ||
| Q2 25 | -160.3% | 4.6% | ||
| Q1 25 | 6.5% | 6.1% | ||
| Q4 24 | -40.7% | 0.7% | ||
| Q3 24 | 3.3% | 12.3% | ||
| Q2 24 | 1.1% | 21.0% | ||
| Q1 24 | 20.9% | 1.1% |
每股收益（稀释后）ASHDOC
| Q4 25 | $-0.26 | $0.16 | ||
| Q3 25 | $0.83 | $-0.17 | ||
| Q2 25 | $-16.21 | $0.05 | ||
| Q1 25 | $0.65 | $0.06 | ||
| Q4 24 | $-3.50 | $0.02 | ||
| Q3 24 | $0.34 | $0.12 | ||
| Q2 24 | $0.12 | $0.21 | ||
| Q1 24 | $2.39 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $304.0M | $467.5M |
| 总债务越低越好 | $1.4B | $9.8B |
| 股东权益账面价值 | $1.9B | $7.5B |
| 总资产 | $4.5B | $20.3B |
| 负债/权益比越低杠杆越低 | 0.74× | 1.31× |
8季度趋势，按日历期对齐
现金及短期投资ASHDOC
| Q4 25 | $304.0M | $467.5M | ||
| Q3 25 | $215.0M | $91.0M | ||
| Q2 25 | $207.0M | $89.4M | ||
| Q1 25 | $168.0M | $70.6M | ||
| Q4 24 | $219.0M | $119.8M | ||
| Q3 24 | $300.0M | $180.4M | ||
| Q2 24 | $399.0M | $106.9M | ||
| Q1 24 | $439.0M | $101.8M |
总债务ASHDOC
| Q4 25 | $1.4B | $9.8B | ||
| Q3 25 | $1.4B | $9.1B | ||
| Q2 25 | $1.4B | $9.0B | ||
| Q1 25 | $1.3B | $8.9B | ||
| Q4 24 | $1.3B | $8.7B | ||
| Q3 24 | $1.3B | $8.6B | ||
| Q2 24 | $1.3B | $8.6B | ||
| Q1 24 | $1.3B | $8.8B |
股东权益ASHDOC
| Q4 25 | $1.9B | $7.5B | ||
| Q3 25 | $1.9B | $7.6B | ||
| Q2 25 | $1.9B | $7.9B | ||
| Q1 25 | $2.6B | $8.2B | ||
| Q4 24 | $2.6B | $8.4B | ||
| Q3 24 | $2.9B | $8.6B | ||
| Q2 24 | $3.0B | $8.8B | ||
| Q1 24 | $3.1B | $8.9B |
总资产ASHDOC
| Q4 25 | $4.5B | $20.3B | ||
| Q3 25 | $4.6B | $19.6B | ||
| Q2 25 | $4.6B | $19.8B | ||
| Q1 25 | $5.2B | $19.8B | ||
| Q4 24 | $5.2B | $19.9B | ||
| Q3 24 | $5.6B | $20.0B | ||
| Q2 24 | $5.7B | $20.2B | ||
| Q1 24 | $5.9B | $20.5B |
负债/权益比ASHDOC
| Q4 25 | 0.74× | 1.31× | ||
| Q3 25 | 0.73× | 1.20× | ||
| Q2 25 | 0.73× | 1.14× | ||
| Q1 25 | 0.52× | 1.08× | ||
| Q4 24 | 0.51× | 1.04× | ||
| Q3 24 | 0.47× | 1.00× | ||
| Q2 24 | 0.45× | 0.98× | ||
| Q1 24 | 0.42× | 0.99× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $125.0M | $1.3B |
| 自由现金流经营现金流 - 资本支出 | $111.0M | $357.0M |
| 自由现金流率自由现金流/营收 | 28.8% | 49.6% |
| 资本支出强度资本支出/营收 | 3.6% | 124.4% |
| 现金转化率经营现金流/净利润 | — | 10.99× |
| 过去12个月自由现金流最近4个季度 | $200.0M | — |
8季度趋势，按日历期对齐
经营现金流ASHDOC
| Q4 25 | $125.0M | $1.3B | ||
| Q3 25 | $40.0M | $315.0M | ||
| Q2 25 | $115.0M | $363.5M | ||
| Q1 25 | $9.0M | $279.4M | ||
| Q4 24 | $-30.0M | $1.1B | ||
| Q3 24 | $80.0M | $318.2M | ||
| Q2 24 | $127.0M | $316.2M | ||
| Q1 24 | $54.0M | $152.6M |
自由现金流ASHDOC
| Q4 25 | $111.0M | $357.0M | ||
| Q3 25 | $6.0M | — | ||
| Q2 25 | $95.0M | — | ||
| Q1 25 | $-12.0M | — | ||
| Q4 24 | $-53.0M | $333.7M | ||
| Q3 24 | $42.0M | — | ||
| Q2 24 | $98.0M | — | ||
| Q1 24 | $20.0M | — |
自由现金流率ASHDOC
| Q4 25 | 28.8% | 49.6% | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 20.5% | — | ||
| Q1 25 | -2.5% | — | ||
| Q4 24 | -13.1% | 47.8% | ||
| Q3 24 | 8.1% | — | ||
| Q2 24 | 18.0% | — | ||
| Q1 24 | 3.5% | — |
资本支出强度ASHDOC
| Q4 25 | 3.6% | 124.4% | ||
| Q3 25 | 7.1% | — | ||
| Q2 25 | 4.3% | — | ||
| Q1 25 | 4.4% | — | ||
| Q4 24 | 5.7% | 105.6% | ||
| Q3 24 | 7.3% | — | ||
| Q2 24 | 5.3% | — | ||
| Q1 24 | 5.9% | — |
现金转化率ASHDOC
| Q4 25 | — | 10.99× | ||
| Q3 25 | 1.29× | — | ||
| Q2 25 | — | 11.48× | ||
| Q1 25 | 0.29× | 6.52× | ||
| Q4 24 | — | 235.43× | ||
| Q3 24 | 4.71× | 3.71× | ||
| Q2 24 | 21.17× | 2.17× | ||
| Q1 24 | 0.45× | 22.85× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASH
| Personal Care And Household | $123.0M | 32% |
| Other | $120.0M | 31% |
| Specialty Additives | $36.0M | 9% |
| Intermediates And Solvents | $31.0M | 8% |
| Personal Care | $30.0M | 8% |
| Life Sciences | $27.0M | 7% |
| Intermediates | $19.0M | 5% |
DOC
暂无分部数据
